DB
MRK icon

Dmitry Balyasny’s Merck MRK Stock Holding History

Dmitry Balyasny’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.11M Sell
55,300
-54,800
-50% -$6.41M 0.01% 1216
2026
Q1 		$13.2M Sell
110,100
-124,600
-53% -$14.4M 0.02% 883
2025
Q4 		$24.7M Buy
234,700
+189,300
+417% +$17.8M 0.03% 614
2025
Q3 		$3.81M Sell
45,400
-9,300
-17% -$766K ﹤0.01% 1501
2025
Q2 		$4.33M Sell
54,700
-64,700
-54% -$5.14M 0.01% 1360
2025
Q1 		$10.7M Buy
119,400
+88,200
+283% +$8.23M 0.02% 878
2024
Q4 		$3.1M Buy
31,200
+800
+3% +$82.5K ﹤0.01% 1493
2024
Q3 		$3.45M Sell
30,400
-5,500
-15% -$653K 0.01% 1430
2024
Q2 		$4.44M Buy
35,900
+3,200
+10% +$412K 0.01% 1224
2024
Q1 		$4.31M Sell
32,700
-11,500
-26% -$1.42M 0.01% 1281
2023
Q4 		$4.82M Buy
44,200
+12,800
+41% +$1.33M 0.01% 1125
2023
Q3 		$3.23M Buy
+31,400
New +$3.38M 0.01% 1250
2023
Q1 		– Sell
-18,400
Closed -$2.04M – 2968
2022
Q4 		$2.04M Sell
18,400
-109,600
-86% -$11.2M 0.01% 1407
2022
Q3 		$11M Sell
128,000
-321,900
-72% -$28.7M 0.03% 646
2022
Q2 		$41M Buy
449,900
+397,300
+755% +$35.2M 0.13% 197
2022
Q1 		$4.32M Buy
+52,600
New +$4.15M 0.01% 1016
2021
Q3 		– Sell
-11,000
Closed -$855K – 2255
2021
Q2 		$855K Buy
+11,000
New +$818K ﹤0.01% 1361
2019
Q4 		– Sell
-157,200
Closed -$12.6M – 1363
2019
Q3 		$12.6M Buy
+157,200
New +$12.6M 0.09% 341
2019
Q2 		– Sell
-104,800
Closed -$8.32M – 1640
2019
Q1 		$8.32M Buy
+104,800
New +$7.84M 0.06% 434

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dmitry Balyasny's MRK Position: Q2 2026 in Review

Dmitry Balyasny reduced its Merck (MRK) stake by 97% in Q2 2026, selling an estimated $206M and leaving 56,028 shares worth $7.2M. The position accounts for 0.01% of the portfolio, ranked #1210.

Dmitry Balyasny first reported a position in MRK in Q3 2013 and has held it in 44 quarters since. The position peaked at $230M in Q4 2025. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Dmitry Balyasny held 56,028 shares of Merck worth $7.2M as of Q2 2026.
  • Dmitry Balyasny sold 1,756,580 Merck shares in Q2 2026, an estimated $206M.
  • Merck made up 0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1210 holding.
  • Dmitry Balyasny first reported a position in Merck in Q3 2013 and has held it in 44 quarters since.
  • Dmitry Balyasny's Merck position peaked at $230M in Q4 2025.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.